Literature DB >> 25225244

Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin.

T Zangari1, A R Melton-Celsa1, A Panda2, M A Smith1, I Tatarov3, L De Tolla4, A D O'Brien5.   

Abstract

Shiga toxin (Stx)-producing Escherichia coli (STEC) causes hemorrhagic colitis and the hemolytic-uremic syndrome (HUS). STEC strains may produce Stx1a and/or Stx2a or variants of either toxin. A 2006 spinach-associated outbreak of STEC O157:H7 resulted in higher hospitalization and HUS rates than previous STEC outbreaks. The spinach isolate, strain K3995, contains both stx2a and stx2c. We hypothesized that the enhanced virulence of K3995 reflects the combination of stx2 alleles (carried on lysogenic phages) and/or the amount of Stx2 made by that strain. We compared the virulence of K3995 to those of other O157:H7 isolates and an isogenic Stx2 mutant in rabbits and mice. We also measured the relative levels of Stx2 produced from those strains with or without induction of the stx-carrying phage. Some rabbits infected with K3995 exhibited intestinal pathology and succumbed to infection, while none of those infected with O157:H7 strain 2812 (Stx1a(+) Stx2a(+)) died or showed pathological signs. Rabbits infected with the isogenic Stx2a mutant K3995 stx2a::cat were not colonized as well as those infected with K3995 and exhibited no signs of disease. In the streptomycin-treated mouse model, more animals infected with K3995 died than did those infected with O157:H7 strain 86-24 (Stx2a(+)). Additionally, K3995 produced higher levels of total Stx2 and toxin phage DNA in cultures after phage induction than did 86-24. Our results demonstrate the greater virulence of K3995 compared to other O157:H7 strains in rabbits and mice. We conclude that this enhanced virulence is linked to higher levels of Stx2 expression as a consequence of increased phage induction.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25225244      PMCID: PMC4249278          DOI: 10.1128/IAI.02361-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  First-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli O157.

Authors:  Eckhard Strauch; Christoph Schaudinn; Lothar Beutin
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks.

Authors:  Shannon D Manning; Alifiya S Motiwala; A Cody Springman; Weihong Qi; David W Lacher; Lindsey M Ouellette; Janice M Mladonicky; Patricia Somsel; James T Rudrik; Stephen E Dietrich; Wei Zhang; Bala Swaminathan; David Alland; Thomas S Whittam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

3.  Monoclonal antibody 11E10, which neutralizes shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin.

Authors:  Michael J Smith; Angela R Melton-Celsa; James F Sinclair; Humberto M Carvalho; Cory M Robinson; Alison D O'Brien
Journal:  Infect Immun       Date:  2009-05-11       Impact factor: 3.441

4.  Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence.

Authors:  Bridget R Kulasekara; Michael Jacobs; Yang Zhou; Zaining Wu; Elizabeth Sims; Channakhone Saenphimmachak; Laurence Rohmer; Jennifer M Ritchie; Matthew Radey; Matthew McKevitt; Theodore Larson Freeman; Hillary Hayden; Eric Haugen; Will Gillett; Christine Fong; Jean Chang; Viktoriya Beskhlebnaya; Matthew K Waldor; Mansour Samadpour; Thomas S Whittam; Rajinder Kaul; Mitchell Brittnacher; Samuel I Miller
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 5.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts.

Authors:  H Michino; K Araki; S Minami; S Takaya; N Sakai; M Miyazaki; A Ono; H Yanagawa
Journal:  Am J Epidemiol       Date:  1999-10-15       Impact factor: 4.897

7.  Escherichia coli O157:H7 outbreak associated with an improperly chlorinated swimming pool.

Authors:  M S Friedman; T Roels; J E Koehler; L Feldman; W F Bibb; P Blake
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

8.  Differences in adherence and virulence gene expression between two outbreak strains of enterohaemorrhagic Escherichia coli O157 : H7.

Authors:  Galeb S Abu-Ali; Lindsey M Ouellette; Scott T Henderson; Thomas S Whittam; Shannon D Manning
Journal:  Microbiology (Reading)       Date:  2009-11-05       Impact factor: 2.777

9.  Strategies to reduce person-to-person transmission during widespread Escherichia coli O157:H7 outbreak.

Authors:  Edmund Y W Seto; Jeffrey A Soller; John M Colford
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

10.  The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2.

Authors:  R Serra-Moreno; J Jofre; M Muniesa
Journal:  J Bacteriol       Date:  2008-05-09       Impact factor: 3.490

View more
  6 in total

1.  Geographically distinct Escherichia coli O157 isolates differ by lineage, Shiga toxin genotype, and total shiga toxin production.

Authors:  Glen E Mellor; Narelle Fegan; Kari S Gobius; Helen V Smith; Amy V Jennison; Beatriz A D'Astek; Marta Rivas; Smriti Shringi; Katherine N K Baker; Thomas E Besser
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

2.  Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli Infection.

Authors:  Sabrina Mühlen; Isabell Ramming; Marina C Pils; Martin Koeppel; Jana Glaser; John Leong; Antje Flieger; Bärbel Stecher; Petra Dersch
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7.

Authors:  K A Eaton; C Fontaine; D I Friedman; N Conti; C J Alteri
Journal:  Vet Pathol       Date:  2017-02-08       Impact factor: 2.221

Review 4.  Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli.

Authors:  Sabrina Mühlen; Petra Dersch
Journal:  Front Cell Infect Microbiol       Date:  2020-05-06       Impact factor: 5.293

5.  Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a.

Authors:  Lisa M Russo; Angela R Melton-Celsa; Alison D O'Brien
Journal:  J Infect Dis       Date:  2016-01-06       Impact factor: 5.226

6.  Nitric Oxide Induced stx2 Expression Is Inhibited by the Nitric Oxide Reductase, NorV, in a Clade 8 Escherichia coli O157:H7 Outbreak Strain.

Authors:  Rim Al Safadi; Michelle L Korir; Shannon D Manning
Journal:  Microorganisms       Date:  2022-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.